Aniline, 4,4'-methylenedi-
RTECS #
BY5425000
CAS #
Updated
March 2019
Molecular Weight
198.29
Molecular Formula
C13H14N2
Synonyms
4-(4-Aminobenzyl)aniline
4,4'-Diaminodiphenylmethan (German)
4,4'-Diaminodiphenylmethane
4,4'-Diphenylmethanediamine
4,4'-Methylene dianiline
4,4'-Methylenebis(benzeneamine)
4,4'-Methylenebisaniline
4,4'-Methylenedianiline
4,4-Methylenedianiline (ACGIH)
Ancamine TL
Araldite hardener 972
Avaldite HT 972
Benzenamine, 4,4'-methylenebis-
Bis(4-aminophenyl)methane
Bis(p-aminophenyl)methane
Bis-p-aminofenylmethan (Czech)
Curithane
Dadpm
DAPM
Di-(4-aminophenyl)methane
Diaminodiphenylmethane
Dianilinomethane
Epicure DDM
Epikure DDM
HT 972
Jeffamine AP-20
MDA
Methylenebis(aniline)
Methylenedianiline
p,p'-Diaminodifenylmethan (Czech)
p,p'-Diaminodiphenylmethane
p,p'-Methylenedianiline
Sumicure M
Tonox
4,4'-Diaminodiphenylmethan (German)
4,4'-Diaminodiphenylmethane
4,4'-Diphenylmethanediamine
4,4'-Methylene dianiline
4,4'-Methylenebis(benzeneamine)
4,4'-Methylenebisaniline
4,4'-Methylenedianiline
4,4-Methylenedianiline (ACGIH)
Ancamine TL
Araldite hardener 972
Avaldite HT 972
Benzenamine, 4,4'-methylenebis-
Bis(4-aminophenyl)methane
Bis(p-aminophenyl)methane
Bis-p-aminofenylmethan (Czech)
Curithane
Dadpm
DAPM
Di-(4-aminophenyl)methane
Diaminodiphenylmethane
Dianilinomethane
Epicure DDM
Epikure DDM
HT 972
Jeffamine AP-20
MDA
Methylenebis(aniline)
Methylenedianiline
p,p'-Diaminodifenylmethan (Czech)
p,p'-Diaminodiphenylmethane
p,p'-Methylenedianiline
Sumicure M
Tonox
Skin and Eye Irritation and References
Route/Organism | Dose | Effect | Reference |
---|---|---|---|
eye /rabbit | 100 mg/24H | moderate | 85JCAE -,481,1986 |
skin /child | 0.5%/2D | CODEDG 60,346,2009 | |
skin /man | 0.5%/2D | CODEDG 60,346,2009 | |
skin /woman | 0.5%/2D | CODEDG 60,346,2009 |
Mutation Data and Reference
System Test | Route/Organism/Tissue | Dose | Reference |
---|---|---|---|
Cytogenetic Analysis | fibroblast/hamster | 125 mg/L/3H | MUREAV 497,29,2001 |
DNA adduct | other cell types/human | 50 gm/L/24H | TXCYAC 196,65,2004 |
DNA Damage | liver/human | 10 µmol/L/4H | TXAPA9 182,219,2002 |
DNA Damage | other cell types/human | 10 µmol/L/4H | TXAPA9 182,219,2002 |
DNA Damage | liver/rat | 10 µmol/L/4H | TXAPA9 182,219,2002 |
DNA Damage | other cell types/rat | 100 µmol/L/4H | TXAPA9 182,219,2002 |
DNA Damage | intraperitoneal/rat | 370 µmol/kg | CRNGDP 2,1317,1981 |
DNA Damage | liver/rat | 2 mmol/L | MUREAV 368,59,1996 |
DNA Damage | oral/mouse | 250 mg/kg | MUREAV 440,1,1999 |
micronucleus test | fibroblast/hamster | 50 mg/L | TOSCF2 58,102,2000 |
micronucleus test | intraperitoneal/rat | 400 mg/kg | MUREAV 583,133,2005 |
micronucleus test | oral/rat | 875 mg/kg/14D | MUREAV 780-781,2,2015 |
mutation in microorganisms | /Salmonella typhimurium | 50 µg/plate/20M (+enzymatic activation step) | MUTAEX 20,217,2005 |
mutation in microorganisms | /Salmonella typhimurium | 50 µg/plate/48H (+enzymatic activation step) | MUTAEX 20,217,2005 |
mutation in microorganisms | /Salmonella typhimurium | 250 µg/plate (+enzymatic activation step) | MUREAV 67,123,1979 |
mutation in microorganisms | /Salmonella typhimurium | 1 nmol/plate/20M | EMMUEG 38,268,2001 |
sister chromatid exchange | intraperitoneal/mouse | 9 mg/kg | MUREAV 108,225,1983 |
Unscheduled DNA Synthesis | liver/rat | 10 µmol/L | MUREAV 204,683,1988 |
Tumorigenic Data and References
Route/Organism | Dose | Effect | Reference |
---|---|---|---|
oral/rat | lowest published toxic dose: 320 mg/kg | Tumorigenic: Equivocal tumorigenic agent by RTECS criteria Liver: Tumors Kidney, Ureter, and Bladder: Kidney tumors | NATUAS 219,1162,1968 |
subcutaneous/rat | lowest published toxic dose: 1410 mg/kg | Tumorigenic: Equivocal tumorigenic agent by RTECS criteria Liver: Tumors | NATWAY 57,247,1970 |
Acute Toxicity Data and References
Route/Organism | Dose | Effect | Reference |
---|---|---|---|
intraperitoneal/rat | lethal dose (50 percent kill): 193 mg/kg | ZHYGAM 20,393,1974 | |
oral/Dog | lowest published lethal dose: 300 mg/kg | Gastrointestinal: Hypermotility, diarrhea Gastrointestinal: Nausea or vomiting | TXCYAC 11,185,1978 |
oral/guinea pig | lethal dose (50 percent kill): 260 mg/kg | ZHYGAM 20,393,1974 | |
oral/man | lowest published toxic dose: 8420 µg/kg | Behavioral: Rigidity (includes catalepsy) Liver: Jaundice, other or unclassified Liver: Other changes | BMJOAE 1,514,1966 |
oral/mouse | lethal dose (50 percent kill): 264 mg/kg | NTIS** OTS0555063 | |
oral/rabbit | lethal dose (50 percent kill): 620 mg/kg | ZHYGAM 20,393,1974 | |
oral/rat | lethal dose (50 percent kill): 517 mg/kg | NTIS** OTS0539752 | |
oral/rat | lowest published toxic dose: 50 mg/kg | Liver: Other changes Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Transaminases Biochemical: Metabolism (intermediary): Effect on inflammation or mediation of inflammation | TOXID9 44,393,2005 |
oral/rat | lowest published toxic dose: 25 mg/kg | Liver: Hepatitis (hepatocellular necrosis), zonal Liver: Changes in liver weight Endocrine: Changes in spleen weight | TOXID9 78,312,2004 |
oral/rat | lethal dose (50 percent kill): 100 mg/kg | Liver: Multiple effects | TOXID9 78,312,2004 |
oral/rat | lowest published toxic dose: 25 mg/kg | Liver: Liver function tests impaired Liver: Other changes Biochemical: Metabolism (intermediary): Effect on mitochondrial function | TOLED5 169,13,2007 |
oral/rat | lowest published toxic dose: 81 mg/kg | Kidney, Ureter, and Bladder: Other changes | TXCYAC 246,91,2008 |
skin/rabbit | lethal dose (50 percent kill): 200 mg/kg | NTIS** OTS0555064 | |
subcutaneous/Dog | lowest published lethal dose: 400 mg/kg | AEXPBL 58,167,1907 | |
subcutaneous/rat | lethal dose (50 percent kill): 200 mg/kg | NATWAY 57,247,1970 |
Other Multiple Dose Data and References
Route/Organism | Dose | Effect | Reference |
---|---|---|---|
oral/Dog | lowest published toxic dose: 456 mg/kg/15W- intermittent | Liver: Fatty liver degeneration Kidney, Ureter, and Bladder: Interstitial nephritis Blood: Normocytic anemia | JJATDK 11,367,1991 |
oral/rat | lowest published toxic dose: 7980 mg/kg/19W- continuous | Endocrine: Thyroid weight (goiter) Nutritional and Gross Metabolic: Weight loss or decreased weight gain | JJIND8 72,471,1984 |
oral/rat | lowest published toxic dose: 243 mg/kg/3D- intermittent | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Transaminases | TXCYAC 246,91,2008 |
oral/rat | lowest published toxic dose: 405 mg/kg/5D- intermittent | Liver: Other changes Biochemical: Metabolism (intermediary): Effect on inflammation or mediation of inflammation | TXCYAC 246,91,2008 |
oral/rat | lowest published toxic dose: 218.4 mg/kg/14D- intermittent | Liver: Tumors | MUREAV 780-781,2,2015 |
oral/rat | lowest published toxic dose: 875 mg/kg/14D- intermittent | Liver: Changes in liver weight | MUREAV 780-781,2,2015 |
oral/rat | lowest published toxic dose: 1120 mg/kg/28D- intermittent | Liver: Changes in liver weight | MUREAV 780-781,2,2015 |
oral/rat | lowest published toxic dose: 16800 mg/kg/40W- continuous | Liver: Other changes Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Dehydrogenases | TXAPA9 48,145,1979 |
oral/rat | lowest published toxic dose: 6972 mg/kg/12W- intermittent | Liver: Other changes Blood: Changes in spleen Biochemical: Metabolism (intermediary): Other proteins | APPFAR 26,352,1969 |
oral/rat | lowest published toxic dose: 1386 mg/kg/1W- intermittent | Behavioral: Ataxia Liver: Changes in liver weight Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field | NTIS** OTS0555074 |
Reviews
Organization | Standard | Reference |
---|---|---|
American Conference of Governmental Industrial Hygienists (ACGIH) | Threshold Limit Value-time-weighted average 0.1 ppm (skin) | DTLVS* TLV/BEI,2013 |
American Conference of Governmental Industrial Hygienists (ACGIH) | Threshold Limit Value-Confirmed animal carcinogen | DTLVS* TLV/BEI,2013 |
International Agency for Research on Cancer (IARC) | Cancer Review:Animal Sufficient Evidence | IMEMDT 39,347,1986 |
International Agency for Research on Cancer (IARC) | Cancer Review:Human No Adequate Data | IMEMDT 39,347,1986 |
International Agency for Research on Cancer (IARC) | Cancer Review:Group 2B | IMSUDL 7,56,1987 |
TOXICOLOGY REVIEW | NTIS** DE85-017376 | |
TOXICOLOGY REVIEW | TOLED5 134,39,2002 | |
TOXICOLOGY REVIEW | MUREAV 543,201,2003 | |
TOXICOLOGY REVIEW | MUREAV 567,227,2004 | |
TOXICOLOGY REVIEW | DIMON* 39,678,1993 | |
TOXICOLOGY REVIEW | HUTOX* -,649,1996 | |
TOXICOLOGY REVIEW | TXAPA9 243,154,2010 | |
TOXICOLOGY REVIEW | RTOPDW 55,43,2009 | |
TOXICOLOGY REVIEW | RTOPDW 61,1,2011 |
Standards and Regulations
NIOSH Documentation and Surveillance
Organization | Standard | Reference |
---|---|---|
National Institute for Occupational Safety and Health (NIOSH) Recommended Exposure Level TO 4,4'-METHYLENEDIANILINE-air | Carcinogen lowest feasible conc. | NIOSH* DHHS #92-100,1992 |
National Occupational Exposure Survey 1983 | Hazard Code 83609; Number of Industries 25; Total Number of Facilities 741; Number of Occupations 30; Total Number of Employees Exposed 15170; Total Number of Female Employees Exposed 3407 | |
National Occupational Hazard Survey 1974 | Hazard Code 83609; Number of Industries 16; Total Number of Facilities 363; Number of Occupations 27; Total Number of Employees Exposed 9163 |
Status in Federal Agencies
Organization | Reference |
---|---|
ATSDR TOXICOLOGY PROFILE (NTIS** PB/99/102568/AS) | |
EPA TSCA 8(a) PRELIMINARY ASSESSMENT INFORMATION, FINAL RULE | FEREAC 47,26992,82 |
EPA TSCA Section 8(b) CHEMICAL INVENTORY | |
EPA TSCA Section 8(d) unpublished health/safety studies | |
EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001 | |
NIOSH Analytical Method, 1994: 4,4'-Methylenedianiline, 5029 | |
NIOSH CURRENT INTELLIGENCE BULLETIN 8, 1976 AND BULLETIN 47, 1986 | |
NTP 14th Report on Carcinogens,2016:Reasonably anticipated to be human carcinogen | |
On EPA IRIS database | |
OSHA ANALYTICAL METHOD #ID-57 |
Page last reviewed: November 16, 2018
Content
source: National Institute for Occupational Safety and Health